Study

EORTC-20884-LYMG

Prospective randomized controlled trial of adjuvant involved field radiotherapy after MOPP/ABV hybrid chemotherapy in advanced Hodgkin disease. H34 Trial

Study documentation Back to result

Trial Status

LT-FU ongoing

Dates

Date of activation: 15-Sep-1989
Date Step1 close: 01-May-2000

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 615

Treatment

Radiotherapy, Drug

Study Staff

  • Laurens Vinckier (Pharmacovigilance Manager), EORTC Headquarters, Brussels

Type of cancer

  • Hodgkins Disease

Participating groups

  • EORTC Lymphoma Group
  • Pierre et Marie Curie Group

Protocol summary

http://clinicaltrials.gov/study/NCT00002462

NCT number

NCT00002462